Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy.
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y, Hori Y, Kiyoshima K, Negishi T, Kuroiwa K, Seki N, Tomisaki I, Nakamura M, Harada K, Fujimoto N.
Minato A, et al. Among authors: nakamura m.
Anticancer Res. 2024 Aug;44(8):3419-3426. doi: 10.21873/anticanres.17162.
Anticancer Res. 2024.
PMID: 39060065